The intersection of Epstein-Barr virus with the germinal center

Journal of Virology

Volumn 83, Issue 8, 2009, Pages 3968-3976

  Roughan, Jill E ^a,b   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CELL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; PROTEIN BCL 6; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); BCL6 PROTEIN, HUMAN; CYTIDINE DEAMINASE; DNA BINDING PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LATENT VIRUS INFECTION; MEMORY CELL; MOLECULAR MODEL; NONHUMAN; PALATINE TONSIL; PHENOTYPE; PRIORITY JOURNAL; TONSIL CELL; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS PATHOGENESIS; ADOLESCENT; B LYMPHOCYTE; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 4;

ADOLESCENT; B-LYMPHOCYTES; CYTIDINE DEAMINASE; DNA-BINDING PROTEINS; GERMINAL CENTER; HERPESVIRUS 4, HUMAN; HUMANS; PALATINE TONSIL; VIRUS LATENCY;

EID: 64049099870     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02609-08     Document Type: Article

References (52)

1. Allen, C. D., K. M. Ansel, C. Low, R. Lesley, H. Tamamura, N. Fujii, and J. G. Cyster. 2004. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5:943-952. (Pubitemid 39276239)
2. Angelin-Duclos, C., G. Cattoretti, K. I. Lin, and K. Calame. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165:5462-5471.
3. Arpin, C., J. Dechanet, K. C. Van, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y. J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720-722.
4. Audouin, J., J. Diebold, and G. Pallesen. 1992. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J. Pathol. 167:381-384.
5. Babcock, G. J., L. L. Decker, M. Volk, and D. A. Thorley-Lawson. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404.
6. Babcock, G. J., D. Hochberg, and A. D. Thorley-Lawson. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497-506.
7. Caldwell, R. G., J. B. Wilson, S. J. Anderson, and R. Longnecker. 1998. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405-411.
8. Casola, S., K. L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot, J. L. Kutok, M. C. Carroll, and K. Rajewsky. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5:317-327. (Pubitemid 38332129)
9. + B cells harbor the virus in X-linked lymphoproliferative disease patients. Blood 112:672-679.
10. Conacher, M., R. Callard, K. McAulay, H. Chapel, D. Webster, D. Kumararatne, A. Chandra, G. Spickett, P. A. Hopwood, and D. H. Crawford. 2005. Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population. J. Virol. 79:11128-11134. (Pubitemid 41170653)
11. Dent, A. L., A. L. Shaffer, X. Yu, D. Allman, and L. M. Staudt. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592.
12. Dorsett, Y., D. F. Robbiani, M. Jankovic, B. Reina-San-Martin, T. R. Eisenreich, and M. C. Nussenzweig. 2007. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204:2225-2232. (Pubitemid 47360881)
13. Gires, O., U. Zimber-Strobl, R. Gonnella, M. Ueffing, G. Marschall, R. Zeidler, D. Pich, and W. Hammerschmidt. 1997. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16:6131-6140. (Pubitemid 27458333)
14. Hadinoto, V., M. Shapiro, T. C. Greenough, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2008. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111:1420-1427.
15. He, B., N. Raab-Traub, P. Casali, and A. Cerutti. 2003. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171:5215-5224. (Pubitemid 37432806)
16. + T cells and the virus-host balance. J. Clin. Investig. 115:2546-2555.
17. Hochberg, D., J. M. Middeldorp, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2004. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. USA 101:239-244.
18. Hochberg, D., T. Souza, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2004. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J. Virol. 78:5194-5204.
19. - B cell population represents a heterogeneous subset of cells comprising centroblasts, centrocytes, and plasmablasts, prompting phenotypical revision. J. Immunol. 177:4341-4349.
20. Hudnall, S. D., Y. Ge, L. Wei, N. P. Yang, H. Q. Wang, and T. Chen. 2005. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod. Pathol. 18:519-527. (Pubitemid 40478115)
21. Khan, G., E. M. Miyashita, B. Yang, G. J. Babcock, and D. A. Thorley- Lawson. 1996. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5:173-179.
22. Klein, U., and R. Dalla-Favera. 2008. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8:22-33.
23. Klein, U., Y. Tu, G. A. Stolovitzky, J. L. Keller, J. Haddad, Jr., V. Miljkovic, G. Cattoretti, A. Califano, and R. Dalla-Favera. 2003. Transcriptional analysis of the B cell germinal center reaction. Proc. Natl. Acad. Sci. USA 100:2639-2644.
24. Kulwichit, W., R. H. Edwards, E. M. Davenport, J. F. Baskar, V. Godfrey, and N. Raab-Traub. 1998. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. USA 95:11963-11968.
25. Kuppers, R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3:801-812.
26. Kurth, J., M. L. Hansmann, K. Rajewsky, and R. Kuppers. 2003. Epstein- Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc. Natl. Acad. Sci. USA 100:4730-4735.
27. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211-5218.
28. Leanderson, T., E. Kallberg, and D. Gray. 1992. Expansion, selection and mutation of antigen-specific B cells in germinal centers. Immunol. Rev. 126:47-61.
29. Liu, Y. J., and C. Arpin. 1997. Germinal center development. Immunol. Rev. 156:111-126. (Pubitemid 27197197)
30. Liu, Y. J., D. Y. Mason, G. D. Johnson, S. Abbot, C. D. Gregory, D. L. Hardie, J. Gordon, and I. C. MacLennan. 1991. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21:1905-1910.
31. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-139. (Pubitemid 24140411)
32. Miyashita, E. M., B. Yang, K. M. Lam, D. H. Crawford, and D. A. Thorley- Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601.
33. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation- induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.
34. Okazaki, I., K. Yoshikawa, K. Kinoshita, M. Muramatsu, H. Nagaoka, and T. Honjo. 2003. Activation-induced cytidine deaminase links class switch recombination and somatic hypermutation. Ann. N. Y. Acad. Sci. 987:1-8. (Pubitemid 36584001)
35. Panagopoulos, D., P. Victoratos, M. Alexiou, G. Kollias, and G. Mosialos. 2004. Comparative analysis of signal transduction by CD40 and the Epstein- Barr virus oncoprotein LMP1 in vivo. J. Virol. 78:13253-13261. (Pubitemid 39507830)
36. Pascual, V., Y. J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180:329-339. (Pubitemid 24181081)
37. Pasqualucci, L., G. Bhagat, M. Jankovic, M. Compagno, P. Smith, M. Muramatsu, T. Honjo, H. C. Morse III, M. C. Nussenzweig, and R. Dalla-Favera. 2008. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 40:108-112.
38. Rickinson, A. B., and E. Kieff. 2007. Epstein-Barr virus, p. 2655-2700. In D. M. Knipe and P. M. Howley (ed.), Virology, 5th ed., vol.2. Lippincott Williams and Wilkins, Philadelphia, PA.
39. Roy, M. P., C. H. Kim, and E. C. Butcher. 2002. Cytokine control of memory B cell homing machinery. J. Immunol. 169:1676-1682.
40. Schwickert, T. A., R. L. Lindquist, G. Shakhar, G. Livshits, D. Skokos, M. H. Kosco-Vilbois, M. L. Dustin, and M. C. Nussenzweig. 2007. In vivo imaging of germinal centres reveals a dynamic open structure. Nature 446:83-87.
41. Shaffer, A. L., A. Rosenwald, E. M. Hurt, J. M. Giltnane, L. T. Lam, O. K. Pickeral, and L. M. Staudt. 2001. Signatures of the immune response. Immunity 15:375-385.
42. Shaffer, A. L., A. Rosenwald, and L. M. Staudt. 2002. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2:920-932.
43. Siemer, D., J. Kurth, S. Lang, G. Lehnerdt, J. Stanelle, and R. Kuppers. 2008. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol. Immunol. 45:3133-3141.
44. Souza, T. A., B. D. Stollar, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2007. Influence of EBV on the peripheral blood memory B cell compartment. J. Immunol. 179:3153-3160.
45. Souza, T. A., B. D. Stollar, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley- Lawson. 2005. Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc. Natl. Acad. Sci. USA 102:18093-18098.
46. Staudt, L. M. 2000. The molecular and cellular origins of Hodgkin's disease. J. Exp. Med. 191:207-212. (Pubitemid 30060911)
47. Swanson-Mungerson, M. A., R. G. Caldwell, R. Bultema, and R. Longnecker. 2005. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J. Virol. 79:7355-7362.
48. Thorley-Lawson, D. A. 2001. Epstein-Barr virus, p. 970-985. In K. F. Austen, M. M. Frank, J. P. Atkinson, and H. Cantor (ed.), Sampter's immunologic diseases, 6th ed., vol.2. Williams and Wilkins, Philadelphia, PA.
49. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
50. Thorley-Lawson, D. A., and A. Gross. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350:1328-1337. (Pubitemid 38375368)
51. Uchida, J., T. Yasui, Y. Takaoka-Shichijo, M. Muraoka, W. Kulwichit, N. Raab-Traub, and H. Kikutani. 1999. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300-303.
52. Ye, B. H., G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R. S. Chaganti, P. Rothman, A. M. Stall, P. P. Pandolfi, and R. Dalla-Favera. 1997. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16:161-170. (Pubitemid 27240614)